UHRF1/DNMT1–MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer
Acta Pharmaceutica Sinica B · 2023-05 · 13 (5) · 2086-2106
DOI: 10.1016/j.apsb.2023.02.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-05. Verfasst von Shuye Lin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing 101149, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Commission of Education, East China Normal University, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
As confusion mounts over RNA isoforms involved in phenotypic plasticity, aberrant CpG methylation-mediated disruption of alternative splicing is increasingly recognized as a driver of intratumor heterogeneity (ITH). Protease serine 3 (PRSS3), possessing four splice variants (PRSS3-SVs; PRSS3-V1-V4), is an indispensable trypsin that shows paradoxical effects on cancer development. Here, we found that PRSS3 transcripts and their isoforms were divergently expressed in lung cancer, exhibiting opposing functions and clinical outcomes, namely, oncogenic PRSS3-V1 and PRSS3-V2 versus tumor-suppressive PRSS3-V3, by targeting different downstream genes. We identified an intragenic CpG island (iCpGI) in PRSS3. Hypermethylation of iCpGI was mediated by UHRF1/DNMT1 complex interference with the binding of myeloid zinc finger 1 (MZF1) to regulate PRSS3 transcription. The garlic-derived compound diallyl trisulfide cooperated with 5-aza-2'-deoxycytidine to exert antitumor effects in lung adenocarcinoma cells through site-specific iCpGI demethylation specifically allowing MZF1 to upregulate PRSS3-V3 expression. Epigenetic silencing of PRSS3-V3 via iCpGI methylation (iCpGIm) in BALF and tumor tissues was associated with early clinical progression in patients with lung cancer but not in those with squamous cell carcinoma or inflammatory disease. Thus, UHRF1/DNMT1-MZF1 axis-modulated site-specific iCpGIm regulates divergent expression of PRSS3-SVs, conferring nongenetic functional ITH, with implications for early detection of lung cancer and targeted therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing 101149, China.
- College of Life Sciences & Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
- Department of Endoscopic Diagnosis and Treatment, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing 101149, China.
- CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Förderung
- Beijing Municipal Commission of Education
- East China Normal University
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Lin, S., Xu, H., Qin, L., Pang, M., Wang, Z., Gu, M., Zhang, L., Zhao, C., Hao, X., Zhang, Z., Ding, W., Ren, J., & Huang, J. (2023). UHRF1/DNMT1–MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer. Acta Pharmaceutica Sinica B, 13(5), 2086-2106. https://doi.org/10.1016/j.apsb.2023.02.015
Vancouver
Lin S, Xu H, Qin L, Pang M, Wang Z, Gu M, et al. UHRF1/DNMT1–MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer. Acta Pharmaceutica Sinica B. 2023;13(5):2086-2106. doi:10.1016/j.apsb.2023.02.015
BibTeX
@article{Lin2023,
author = {Lin, Shuye and Xu, Hanli and Qin, Lin and Pang, Mengdi and Wang, Ziyu and Gu, Meng and Zhang, Lishu and Zhao, Cong and Hao, Xuefeng and Zhang, Zhiyun and Ding, Weimin and Ren, Jianke and Huang, Jiaqiang},
title = {UHRF1/DNMT1–MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {5},
pages = {2086--2106},
doi = {10.1016/j.apsb.2023.02.015}
}
EUVIMED